Former Louisiana Attorney General Charles C. Foti, Jr. is leading an investigation into The Beauty Health Company, known by its ticker symbol SKIN. This inquiry is being conducted by his law firm, Kahn Swick & Foti, LLC (KSF), following troubling financial disclosures from the company.
In November 2023, The Beauty Health Company announced disappointing third-quarter results. They reported lower U.S. revenue and significant restructuring charges—totaling $63.1 million—related to updates on their Syndeo devices. As a result, they downgraded their sales projections for the year to between $385 million and $400 million and suspended their long-term financial outlook. To compound matters, CEO Stanleick is stepping down from his position.
This financial turmoil has led to a securities class-action lawsuit against the company. The lawsuit claims that executives failed to share important information, which may have misled investors.
KSF’s focus is to determine if the company’s officers and directors violated their responsibilities to shareholders or broke any state or federal regulations. Such investigations matter because they help ensure that corporate leaders are held accountable for their actions—and protect the rights of investors.
Interestingly, according to a recent survey by the National Investor Relations Institute, 64% of investors believe that transparency is crucial for maintaining trust in publicly traded companies. This emphasizes the need for companies to uphold high standards of disclosure and ethical conduct.
Kahn Swick & Foti ranks among the top law firms in securities litigation, recently recognized for its effectiveness in managing complex cases. They work with both institutional and retail investors to recover losses due to corporate misconduct.
If you have information about The Beauty Health Company’s situation or are an investor looking for support, you can reach out to KSF for further details.
For more on legal rights related to investments, visit KSF Counsel.
